01 Nov
  • By leilanifera
  • Cause in

Capricor Therapeutics

Approach: Cardiac stem cell derived therapy
Funding Impact: Initiation of Phase 1/2 study (HOPE Clinical Trial)
Successful Exit: Stock Return

READ MORE
01 Aug
  • By leilanifera
  • Cause in

Bamboo Therapeutics

Approach: Gene therapy for Duchenne
Funding Impact: Accelerated vector manufacturing capabilities
Successful Exit: Acquired by Pfizer in August 2016

READ MORE